Japan Places Myocarditis Warning on mRNA ‘Vaccines’ – Requires Informed Consent

(by Amy Mek | RAIR Foundation) – Japan announces that public and private sectors can not discriminate against those who refuse the experimental mRNA gene therapy injections.

Japan is now labeling Covid “vaccines” to warn of dangerous and potentially deadly side effects such as myocarditis. In addition, the country is reaffirming its commitment to adverse event reporting requirements to ensure all possible side effects are documented.

These efforts from Japan’s health authority are in stark contrast to the deceptive measures taken by other countries to coerce citizens into taking the injection, downplaying side effects, and discouraging proper adverse event reporting.

Additionally, Japan is emphasizing informed consent and bodily autonomy. Until the coronavirus pandemic, the concept of “informed consent” was considered sacred to healthcare professionals in the West.

Japan is particularly raising concerns about the risks of myocarditis in young men injected with Pfizer or Moderna’s gene–therapy treatment. The country is enforcing a strict legal reporting requirement of side effects that must take place within 28 days of the injections.

Novel Additives: Descriptions Clarify

Three Covid-19 gene-therapy treatments are currently offered in Japan. They include the Pfizer/BioNTech (Comirnaty) and Takeda’s Moderna formulation. The product descriptions (here and here) state that “this product contains an additive that has never been used in a vaccine before.”

Furthermore, the pharmaceutical companies urge you to consult your doctor about the additive if you plan to be injected with it. In addition to the Pfizer and Moderna gene-therapies, Vaxzevria (formerly AstraZeneca) is also administered in Japan. However, Japan only recommends it to people 40-year-old and over. Reference is also made to the new type of additive in the Vaxzevria injections. Read Full Article >